These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 35596145)

  • 41. Seroprevalence of anti-SARS-CoV-2 antibodies among staff at primary healthcare institutions in Prishtina.
    Halili R; Bunjaku J; Gashi B; Hoxha T; Kamberi A; Hoti N; Agahi R; Basha V; Berisha V; Hoxha I
    BMC Infect Dis; 2022 Jan; 22(1):57. PubMed ID: 35034617
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers.
    Allen N; Riain UN; Conlon N; Ferenczi A; Carrion Martin AI; Domegan L; Walsh C; Doherty L; O'Farrelly C; Higgins E; Kerr C; McGrath J; ; Fleming C; Bergin C
    Epidemiol Infect; 2021 Apr; 149():e157. PubMed ID: 33902786
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark.
    Fogh K; Eriksen ARR; Hasselbalch RB; Kristensen ES; Bundgaard H; Nielsen SD; Jørgensen CS; Scharff BFSS; Erikstrup C; Sækmose SG; Holm DK; Aagaard B; Norsk J; Nielsen PB; Kristensen JH; Østergaard L; Ellermann-Eriksen S; Andersen B; Nielsen H; Johansen IS; Wiese L; Simonsen L; Fischer TK; Folke F; Lippert F; Ostrowski SR; Ethelberg S; Koch A; Vangsted AM; Krause TG; Fomsgaard A; Nielsen C; Ullum H; Skov R; Iversen K
    BMC Infect Dis; 2022 Feb; 22(1):143. PubMed ID: 35144550
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High SARS-CoV-2 Seroprevalence in Rural Peru, 2021: a Cross-Sectional Population-Based Study.
    Moreira-Soto A; Pachamora Diaz JM; González-Auza L; Merino Merino XJ; Schwalb A; Drosten C; Gotuzzo E; Talledo M; Arévalo Ramirez H; Peralta Delgado R; Bocanegra Vargas S; Drexler JF
    mSphere; 2021 Dec; 6(6):e0068521. PubMed ID: 34817236
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Seroprevalence of Covid-19 infection among healthcare workers: A study from a tertiary care hospital in the National Capital Region of India.
    Kataria S; Phogat R; Sharma P; Deswal V; Alam S; Singh M; Kumar K; Gupta V; Singh P; Dutt R; Sarma S; Saxena R; Trehan N
    Natl Med J India; 2022; 35(4):219-220. PubMed ID: 36715047
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The kinetics and predictors of anti-SARS-CoV-2 antibodies up to 8 months after symptomatic COVID-19: A Czech cross-sectional study.
    Štěpánek L; Janošíková M; Štěpánek L; Nakládalová M; Boriková A
    J Med Virol; 2022 Aug; 94(8):3731-3738. PubMed ID: 35419860
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SARS-CoV-2 antibodies in Ontario health care workers during and after the first wave of the pandemic: a cohort study.
    Science M; Bolotin S; Silverman M; Nadarajah J; Maguire B; Parekh RS; McGeer A; Schwartz KL; Alexander L; Allen U; Ariyarajah A; Castellani L; Cohn RD; Downing M; Katz K; Kazmi K; Leis JA; Liu D; Pernica JM; Schneiderman JE; Sumaida M; Campigotto A
    CMAJ Open; 2021; 9(4):E929-E939. PubMed ID: 34642255
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Seroprevalence of SARS-CoV-2 among high-risk healthcare workers in a MERS-CoV endemic area.
    Alroqi F; Masuadi E; Alabdan L; Nogoud M; Aljedaie M; Abu-Jaffal AS; Barhoumi T; Almasoud A; Alharbi NK; Alsaedi A; Khan M; Arabi YM; Nasr A
    J Infect Public Health; 2021 Sep; 14(9):1268-1273. PubMed ID: 34479078
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Demographic and occupational determinants of anti-SARS-CoV-2 IgG seropositivity in hospital staff.
    Martin CA; Patel P; Goss C; Jenkins DR; Price A; Barton L; Gupta P; Zaccardi F; Jerina H; Duraisingham S; Brunskill NJ; Khunti K; Pareek M
    J Public Health (Oxf); 2022 Jun; 44(2):234-245. PubMed ID: 33200200
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Seroprevalence of anti-SARS-CoV-2 IgG Antibodies in the Staff of a Public School System in the Midwestern United States.
    Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
    medRxiv; 2020 Oct; ():. PubMed ID: 33140066
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Seroprevalence of Anti-SARS-CoV-2 IgG and IgM Antibodies among Government Employees in Iran.
    Mohammad Hossein ZJ; Mehran D
    Arch Razi Inst; 2023 Oct; 78(5):1413-1420. PubMed ID: 38590673
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A cross-sectional study of SARS-CoV-2 seroprevalence among asymptomatic healthcare workers in a tertiary healthcare centre: Assessing the impact of PPE guidelines.
    Wattal C; Oberoi JK; Goel N; Datta S; Raveendran R; Rao BK; Kumar R
    Indian J Med Microbiol; 2021; 39(4):528-533. PubMed ID: 34688485
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SARS-CoV-2 IgG response in symptomatic and asymptomatic COVID-19-infected healthcare workers.
    Cordova E; Bacelar B; Nieto F; Garibaldi F; Aguirre V; Machuca M; Badia M; Rodriguez C
    Occup Med (Lond); 2021 Aug; 71(4-5):215-218. PubMed ID: 34008016
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Disparities in Seroprevalence of SARS-CoV-2 Immunoglobulin Antibodies in a Large Midwestern Health Care System.
    Fitzpatrick V; Rivelli A; Blair C; Copeland K; Richards J
    Public Health Rep; 2021 May; 136(3):361-367. PubMed ID: 33673779
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Seroprevalence of anti SARS-CoV-2 IgG antibodies among adults in Jammu district, India: A community-based study.
    Kumar D; Sidhu M; Dogra S; Kumar B; Sahni B; Yadav AK; Bala K; Kumari R; Mahajan R; Bavoria S; Kalotra A; Gupta S
    Indian J Med Res; 2022 Jan; 155(1):171-177. PubMed ID: 35859442
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Higher rate of SARS-CoV-2 IgG seropositivity in hospital-based healthcare workers compared to elderly care staff in a Swedish low-prevalence region: a cross-sectional study.
    Ocias LF; Skogstam A; Kjerstadius T; Lundin F; Tevell S
    Infect Dis (Lond); 2021; 53(12):920-929. PubMed ID: 34350813
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SARS-CoV-2 Seroprevalence and Profiles Among Convalescents in Sichuan Province, China.
    Zhou L; Li C; Yang H; Yuan H; Pan M; Cheng X; Xiao C; Su X; Zhu Y; Xu J; Tang J; Du X; Peng H; Chen X; Huang T; Liao H; Xian D; Wang H; Liu W; Zhou P; Zhang Z; Liu J; Wu X; Zhang T
    Front Public Health; 2021; 9():716483. PubMed ID: 34765580
    [No Abstract]   [Full Text] [Related]  

  • 58. Long-term evaluation of the seroprevalence of SARS-CoV-2 IgG and IgM antibodies in recovered patients: a meta-analysis.
    Li Q; Chen L; Li F; He A
    BMC Infect Dis; 2023 Jul; 23(1):444. PubMed ID: 37393304
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Utility of Newborn Dried Blood Spots to Ascertain Seroprevalence of SARS-CoV-2 Antibodies Among Individuals Giving Birth in New York State, November 2019 to November 2021.
    Damjanovic A; Styer LM; Nemeth K; Yauney E; Rock JM; Bievenue R; Hoen R; Ehrbar D; Kay DM; Caggana M; Parker MM
    JAMA Netw Open; 2022 Aug; 5(8):e2227995. PubMed ID: 35994287
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence and associated characteristics of anti-SARS-CoV-2 antibodies in Mexico 5 months after pandemic arrival.
    Díaz-Salazar C; Sánchez-García A; Rodríguez-Gutiérrez R; Camacho-Ortiz A; Saldívar-Rodríguez D; González-González JG
    BMC Infect Dis; 2021 Aug; 21(1):835. PubMed ID: 34412620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.